Serologic and genetic markers do not aid in the determination of the clinical course and severity of patients with inflammatory bowel disease.
Murphy
Seamus J
SJ
Dr Henry D Janowitz Division of Gastroenterology, Mount Sinai Medical Center, New York, New York, USA. s.murphy@qub.ac.uk
Kornbluth
Asher
A
D015415:Biomarkers; D005819:Genetic Markers; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000097:blood / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology; D011379:Prognosis
D015415:Biomarkers; D005819:Genetic Markers